Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chandra

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Cancer Research|September 28, 2016
Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide SignalingJian-Ming Li, Christopher T Petersen, Jing-Xia Li, et al.
Indian Journal of Human Genetics|May 30, 2013
An uncommon case of an adult with del(5)(q) in acute lymphoblastic leukemiaE Venkataswamy, Ashwini R Nargund, Shilpa Prabhudesai, et al.
Clinical Epigenetics|January 29, 2021
Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemiaA D van Dijk, F W Hoff, Y H Qiu, et al.
Infection and Immunity|May 19, 2000
In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidityA S Bayer, R Prasad, J Chandra, et al.
Annals of Surgical Oncology|December 30, 1998
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]M Bouvet, R J Bold, J Lee, et al.
Cancer Immunology, Immunotherapy : CII|September 12, 2020
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)J Chandra, W P Woo, N Finlayson, et al.
Mbio|September 22, 2016
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's DiseaseG Hoarau, P K Mukherjee, C Gower-Rousseau, et al.
Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Cancer Research|September 28, 2016
Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide SignalingJian-Ming Li, Christopher T Petersen, Jing-Xia Li, et al.
Indian Journal of Human Genetics|May 30, 2013
An uncommon case of an adult with del(5)(q) in acute lymphoblastic leukemiaE Venkataswamy, Ashwini R Nargund, Shilpa Prabhudesai, et al.
Clinical Epigenetics|January 29, 2021
Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemiaA D van Dijk, F W Hoff, Y H Qiu, et al.
Infection and Immunity|May 19, 2000
In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidityA S Bayer, R Prasad, J Chandra, et al.
Annals of Surgical Oncology|December 30, 1998
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]M Bouvet, R J Bold, J Lee, et al.
Cancer Immunology, Immunotherapy : CII|September 12, 2020
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)J Chandra, W P Woo, N Finlayson, et al.
Mbio|September 22, 2016
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's DiseaseG Hoarau, P K Mukherjee, C Gower-Rousseau, et al.
Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.
Pageof 15